Long-acting injectable formulations comprising an isoxazoline active agent, methods and uses thereof
US11484528B2 · kind B2 · utility
1Cited by
3References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 30, 2019 |
| Grant date | Nov 1, 2022 |
| Priority date | — |
| Expiry date | Dec 15, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to long-acting injectable formulations for combating parasites in animals, comprising at least one isoxazoline active agent, a poloxamer, and a co-solvent. This invention also provides for improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the long-acting injectable formulations of the invention to the animal in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.